• 1. Efficient synthesis of α- and δ-carbolines by sequential Pd-catalyzed site-selective C–C and twofold C–N coupling reactions
  Tran Quang Hung,Tuan Thanh Dang,Julia Janke,Alexander Villinger,Peter Langer Org. Biomol. Chem. 2015 13 1375
• 2. Novel synthesis of 5-methyl-5,10-dihydroindolo[3,2-b]indoles by Pd-catalyzed C–C and two-fold C–N coupling reactions
  Tran Quang Hung,S?ren Hancker,Alexander Villinger,Stefan Lochbrunner,Tuan Thanh Dang,Aleksej Friedrich,Wolfgang Breitsprecher,Peter Langer Org. Biomol. Chem. 2015 13 583
• 3. Magnetically separable CuFe2O4/reduced graphene oxide nanocomposites: as a highly active catalyst for solvent free oxidative coupling of amines to imines
  Ritu Dhanda,Mazaahir Kidwai RSC Adv. 2016 6 53430
• 4. Interpretation of experimental hydrogen-bond enthalpies and entropies from COSMO polarisation charge densities
  Andreas Klamt,Jens Reinisch,Frank Eckert,Jér?me Graton,Jean-Yves Le Questel Phys. Chem. Chem. Phys. 2013 15 7147
• 5. Amine oxidation. Part IX. The electrochemical oxidation of some tertiary amines: the effect of structure on reactivity
  John R. Lindsay Smith,David Masheder J. Chem. Soc. Perkin Trans. 2 1976 47

• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Introduction to 1-[3-(trifluoromethyl)phenyl]methanamine (CAS No. 2740-83-2)

1-[3-(trifluoromethyl)phenyl]methanamine, also known by its CAS number 2740-83-2, is a versatile organic compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique trifluoromethyl group, which imparts distinct chemical and biological properties, making it a valuable intermediate in the synthesis of various pharmaceuticals and agrochemicals.

The chemical structure of 1-[3-(trifluoromethyl)phenyl]methanamine consists of a benzene ring substituted with a trifluoromethyl group at the 3-position, and an amino group attached to a methyl group. The presence of the trifluoromethyl group enhances the lipophilicity and metabolic stability of the molecule, which are crucial factors in drug design. These properties make it an attractive candidate for the development of novel therapeutic agents.

Recent advancements in medicinal chemistry have highlighted the importance of 1-[3-(trifluoromethyl)phenyl]methanamine in the synthesis of drugs targeting various diseases. For instance, studies have shown that compounds derived from this amine exhibit potent activity against certain types of cancer, particularly those involving solid tumors. The enhanced lipophilicity provided by the trifluoromethyl group facilitates better cellular uptake and distribution, thereby improving the efficacy of these drugs.

In addition to its applications in oncology, 1-[3-(trifluoromethyl)phenyl]methanamine has also been explored for its potential in treating neurological disorders. Research has demonstrated that derivatives of this compound can modulate specific neurotransmitter systems, making them promising candidates for the development of new treatments for conditions such as Alzheimer's disease and Parkinson's disease. The ability to fine-tune the chemical structure allows for the optimization of pharmacological properties, including selectivity and potency.

The synthesis of 1-[3-(trifluoromethyl)phenyl]methanamine typically involves several steps, including the formation of the trifluoromethylated benzene ring and subsequent functionalization to introduce the amino group. Various synthetic routes have been reported in the literature, each with its own advantages and limitations. For example, one common method involves the reaction of 3-trifluoromethylbenzyl chloride with ammonia or a suitable amine source under controlled conditions. This approach provides a reliable and scalable route to produce high-purity 1-[3-(trifluoromethyl)phenyl]methanamine.

The safety and environmental impact of 1-[3-(trifluoromethyl)phenyl]methanamine are important considerations in its use as a chemical intermediate. Rigorous safety assessments have been conducted to ensure that it can be handled and used safely in laboratory and industrial settings. Proper handling procedures, including appropriate personal protective equipment (PPE), are recommended to minimize any potential risks associated with its use.

In conclusion, 1-[3-(trifluoromethyl)phenyl]methanamine (CAS No. 2740-83-2) is a valuable compound with a wide range of applications in medicinal chemistry and pharmaceutical research. Its unique chemical properties make it an essential building block for the development of novel therapeutic agents targeting various diseases. Ongoing research continues to uncover new possibilities for its use, further solidifying its importance in the field.

• 85068-29-7(3,5-bis(Trifluoromethyl)benzylamine)
• 3047-99-2(4-(Trifluoromethyl)benzylamine hydrochloride)
• 90390-11-7(N-methyl-1-[4-(trifluoromethyl)phenyl]methanamine)
• 356058-18-9(4-(4-TRIFLUOROMETHYLPHENYL)BENZYLAMINE)
• 90390-07-1(N-Methyl-n-3-(trifluoromethyl)benzylamine)
• 918810-95-4(3-(difluoromethyl)phenylmethanamine)
• 2944-96-9(Benzenemethanamine,3-(trifluoromethyl)-, hydrochloride (1:1))
• 3300-51-4(4-(Trifluoromethyl)benzylamine)
• 42365-62-8((3,5-Bis(trifluoromethyl)phenyl)methanamine hydrochloride)
• 771581-64-7(1-4-methyl-3-(trifluoromethyl)phenylmethanamine)